Las Vegas, NV -- (SBWIRE) -- 01/08/2014 -- Value Stock Pick is a leading Investment Newsletter. Our Research Team conducts research on different stocks, doing their due diligence to provide a detailed report, including both technical and fundamental analysis, on NYSE, NASDAQ, AMEX, OTCBB and Pink Sheet Stocks. Let’s have a brief look at: GT Advanced Technologies Inc (NASDAQ:GTAT), Vale SA (ADR) (NYSE:VALE), Athersys, Inc. (NASDAQ:ATHX), Novavax, Inc. (NASDAQ:NVAX).
GT Advanced Technologies Inc (NASDAQ:GTAT) ended its recent business day with the advanced of 3.10% and closed at the price of $9.31 after opening at $9.14. The stock traded during its last trading session with the total volume of 5.81 million shares, as compared to its average volume of 5.30 million shares. GT Advanced Technologies Inc. provides crystal growth equipment and solutions for the solar, light emitting diode (LED), and electronics industries worldwide. The company operates through three segments: Polysilicon; Photovoltaic (PV); and Sapphire.
Will GTAT Continue To Move Higher? Find out via this report
Vale SA (ADR) (NYSE:VALE) remained among the day bearish -1.75% and traded with volume of 18.44 million shares in the last session, as compared to average volume of 14.76 million shares. In comparison with 52 week range of $12.39 - $20.97, it faced lowest price of $13.96 during the last trading session whereas its day highest price was $14.44. The company’s total market capitalization is $72.35 billion, along with 5.15 billion shares outstanding. Vale S.A. engages in the research, production, and marketing of iron ore and pellets, nickel, fertilizers, copper, coal, manganese, ferroalloys, cobalt, platinum group metals, and precious metals in Brazil and internationally.
Why Should Investors Buy VALE After the Recent Fall? Just Go Here and Find Out
Athersys, Inc. (NASDAQ:ATHX) showed 2.64 million shares in volume during the last trading session, while the average trading volume remained 1.65 million shares. The stock kicked off its trading session at $3.14 and closed at $3.16 after rallied 3.61%. Athersys, Inc, a biotechnology company, focuses on the research and development in the field of regenerative medicine.
Why Should Investors Buy ATHX After The Recent Gain? Just Go Here and Find Out
Novavax, Inc. (NASDAQ:NVAX) stock traded during its last trading session with the total traded volume of 5.58 million shares versus its average volume of 6.04 million shares. The company opened its trade at the price of $5.25 and its closing price was $5.01 after fell -3.93% for the day. Novavax, Inc., a clinical-stage biopharmaceutical company, focuses on developing recombinant protein nanoparticle vaccines to address a range of infectious diseases.
Has NVAX Found The Bottom and Ready To Move Up? Find Out Here
PLEASE NOTE WELL: The employees of ValueStockPick.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site, Press releases or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Please Read Our Full Disclaimer at http://www.valuestockpick.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)